Valuation : Vista Pharmaceuticals Limited

Market Cap 376M 3.93M 3.39M 3.18M 2.9M 5.47M 5.48M 37.72M 14.72M 190M 14.77M 14.45M 629M P/E 2024
-10.3x
P/E 2025 -13.6x
Enterprise Value 443M 4.63M 3.99M 3.74M 3.42M 6.44M 6.46M 44.41M 17.33M 224M 17.39M 17.02M 741M EV / Sales 2024
7.63x
EV / Sales 2025 8.85x
Free-Float
22.51%
Yield 2024 *
-
Yield 2025 -
1 day+5.32%
1 week+0.63%
Current month-4.37%
1 month-10.96%
3 months-20.75%
6 months-8.12%
Current year-22.11%
1 week 5.86
Extreme 5.86
7.28
1 month 5.81
Extreme 5.81
7.33
Current year 5.71
Extreme 5.71
8.87
1 year 5.71
Extreme 5.71
10.75
3 years 5.71
Extreme 5.71
19.7
5 years 5.71
Extreme 5.71
19.7
10 years 4.51
Extreme 4.51
56.15
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Compliance Officer - 2024-02-09
Director TitleAgeSince
Chairman 76 2014-01-01
Director/Board Member 87 1993-06-15
Director/Board Member 76 2010-02-01
Change 5-day change 1-year change 3-year change Capi.($)
+5.32%+0.63%-39.04%-51.04% 3.88M
+0.35%+0.84%+19.98%+73.55% 48.07B
-0.08%-0.21%+55.27%+121.68% 40.17B
+0.15%+7.52%+20.56%+89.26% 12.42B
+0.25%-1.01%-9.89%+17.70% 12.01B
+0.19%+0.19%+30.98%+150.00% 9.38B
+0.07%+3.80%+27.09%+45.88% 7.78B
+0.04%+0.37%+48.15%-11.95% 7.24B
+2.24%+7.81%+28.93%+240.12% 7.27B
-0.53%-1.53%-34.29%+19.67% 5.33B
Average +0.80%+0.88%+14.77%+69.49% 14.97B
Weighted average by Cap. +0.23%+0.25%+28.02%+88.67%

Financials

2024 2025
Net sales 103M 1.08M 928K 870K 794K 1.5M 1.5M 10.32M 4.03M 51.93M 4.04M 3.95M 172M 101M 1.05M 908K 852K 777K 1.46M 1.47M 10.1M 3.94M 50.86M 3.96M 3.87M 169M
Net income -45.12M -472K -407K -381K -348K -656K -658K -4.53M -1.77M -22.78M -1.77M -1.73M -75.52M -46.49M -486K -419K -393K -359K -676K -678K -4.66M -1.82M -23.47M -1.83M -1.79M -77.81M
Net Debt 78.7M 823K 710K 665K 607K 1.14M 1.15M 7.89M 3.08M 39.73M 3.09M 3.02M 132M 66.71M 698K 601K 564K 515K 970K 973K 6.69M 2.61M 33.68M 2.62M 2.56M 112M
Logo Vista Pharmaceuticals Limited
Vista Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing of pharmaceutical products. The Company offers over the counter and prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company has its United States Food and Drug Administration (USFDA) approved manufacturing facility in India and its marketing and distribution center in United States. Its products include tablet dosage forms and capsule dosage forms. The Company's tablet dosage forms in United States market include sulfamethoxazole & trimethoprim (400/80 mg) and acetaminophen (500 mg) film coated. The Company's tablet dosage forms in Non-United States market include aspirin (300, 325 & 500 mg), atenolol (50 & 100 mg), cotrimoxazole (480 mg), captopril (25 & 50 mg) and frusemide (40 mg). Its capsule dosage forms in Non-United States market include indomethacin (25 mg), piroxicam (10 & 20 mg) and nifedipine (10 mg).
Employees
30
Date Price Change Volume
26-08-28 ₹6.340 +5.32% 8,559
26-08-27 ₹6.020 -0.17% 17,294
26-08-26 ₹6.030 -10.13% 49,500
26-08-25 ₹6.710 +1.82% 35,581
26-08-24 ₹6.590 +2.33% 38,083
  1. Stock Market
  2. Stocks
  3. VISTAPH6 Stock